REGENXBIO Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for RGNX, updated each market day.
RGNX AI Sentiment
AI sees no strong directional signal for REGENXBIO Inc. stock over the next 10 market days.
Prediction date: Sept. 22, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
Sector
Exchange
Market Cap
$542,298,372
Cap Tier
Employees
371
Headquarters
ROCKVILLE, MD
Listed Since
Sept. 17, 2015
Website
RGNX Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
RGNX Volatility
REGENXBIO Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
